PAPERBACK Free Resources |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
| ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 29
REFERENCE S
Ames, B.N., W.E. Durston, E. Yamasaki, and F.D. Lee.
Carcinogens and mutagens: A simple test system combining
liver homogenates for activation and bacteria for
detection. Proc. Natl. Acad. Sci. U.S.A. 70:2281-2285,
1973.
Ames, B.N., L.S. Gold, C.B. Sawyer, and W. Havender.
Carcinogenic potency, pp. 663-670. In T. Sugimura, S .
Kondo, and H. Takebe, Ed s . Environmental Mutagens and
Carcinogens . New York: Lis s, 1982 .
3. Ames, B.N., and L. Haroun. Letter to the editor. Mutat.
Res. 62:393-395, 1979.
4. Ames, BeN. ~ and K. Hooper. Does carcinogenic potency
correlate with mutagenic potency in the Ames assay?
Nature 274:19-20, 1978.
5 . Ame s , B . N ., K. Ho oper, C . B . Sawyer , A. D . Fr iedman , R.
Peto, W. Havender, L.S. Gold, T. Haggin, R.H. Harris, and
M. Rosenfeld. Care inogenic potency: A progress report,
pp. 55-63. In Banbury Report 5. Ethylene Dichloride: A
Potential Health Risk? New York: Cold Spring Harbor
Laboratory, 1980.
6. Ames, B.N., and J. McCann. Validation of the Salmonella
tes t: A reply to Rinkus and Legator. Cancer Res .
41 :4192-4146, 1981.
7 . Anatomy of a human cancer gene . Nature 300 :103 , 1982.
B. Andrews, A.W., L.H. Thibault, and W. Li jinsky. Letter to
the editor. Mutat. Res. 62: 396-39B, 1979.
9. Andrews, A.W., L.H. Thibault, and W. Li jinsky. The rela-
tionship between carcinogenicity and mutagenicity of some
polynuclear hydrocarbons. Mutat. Res. 51: 311-318, 1978.
10. Andrews, A.W., L.H. Thibault, and W. Lijinsky. The rela-
tionship between mutagenicity and carcinogenicity of some
ni trosamines. Hutat. Res. 51: 319-326, 1978.
11. Arlett, C.F. (Coordinator) . The use of cultured mammalian
cells in the UKEMS collaborative genotoxicity trial
(1981~. Mutat. Res. 100:271-276, 1982.
12. Ashby, J., P.A. Lefevre, J.A. Styles, J. Charlesworth,
and D. Paton. Comparisons between carcinogenic potency
and mutagenic potency to Salmonella in a series of
derivatives of 4 - imethylaminoazobenzene (DAB). Mutat.
Res. 93:67-81, 1982.
13. Ashby, J., and J.A. Styles. Does carcinogenic potency
correlate with mutagenic potency in the Ames assay?
Na ture 2 71: 452-455, 19 78.
14. Ashby, J., and J.A. Styles. Factors influencing mutagenic
potency ~n vitro. Nature 274: 20-22, 1978.
Barrett, J.C., and P.O.P. Ts'o. Relationship between
somatic mutation and neoplastic transformation. Proc.
Nat I. Acad. Sci. U. S.~. 75: 3297-3301, 1978.
29
OCR for page 30
16. Barrett, J.C., A. Wang, and J.A. McLachian. Diethyl-
~ ti lbes trot index ices neoplas t ic bans forma t ion wi thou t
measurable gene mutation at two loci. Science
212: 1402-1404, 1981.
17. Bartsch, H. Predictive value of mutagenicity tests in
chemical carcinogenesis. Mutat. Res. 38 :177-190, 1976.
18. Bartsch, H., C. Malaveille, A.-M. Camus, G. Martel-
Planche, G. Brun, A. Hautefeuille, N. Sabatie, A. Barbin,
T. Kuroki, C. Drevon, C. Piccoli, and R. Montesano.
Validation and comparative studies on IB0 chemicals with
S . typh imurium ~ trains and V7 9 Ch inese hams ter ce 1 Is in
_ , .
the presence of various metabolizing systems. Mutat. Res.
76: 1-50, 1980.
Bartsch, H., C. Halaveille, H.F. Stich, E.C. Miller, and
J .A. Miller. Comparative electrophiticity, mutagenicity,
DNA repair induction activity, and carcinogenicity of
some N- and O-acyl derivatives of
N-hydroxy-2-aminofluorene. Cancer Res. 37 :1461-1467, 1977.
20. Bartsch, H., C. Malaveille, R. Tierney, P.L. Grover, and
P. Sims. The association of bacterial mutagenicity of
hydrocarbon-derived "bay region" dihydrodioln with the
Iball indices for carcinogenicity and with the extent of
DNA-binding on mouse skin of the parent hydrocarbons.
Chern.-Biol. Interact. 26:185-196, 1979.
21. Bartsch, H., L. Tomatis, and C. Mala~reille. Qualitative
and quantitative comparisons between mutagenic and
carcinogenic activities of chemicals, pp. 35-72. In J.A.
Heddle, Ed. Mutagenicity: New Horizons in Genetic
Toxicology. New York: Academic Press, 1982.
22. Berenblum, I., and V. Armuth. Two indepedent aspects of
tumor promotion. Biochim. Biophys. Acta 651: 51-63, 1981.
23. Berenblum, I., and R. Shubik. A new, quantitative
approach to the study of the stages of chemical carcino-
genesis in the mouse's skin. Brit. J. Cancer 1:383-391,
194 7 .
Berns tein, L., J. Kaldor, J. McCann, and M.C. Pike. An
empirical approach to the statistical analysis of
mutagenesis data from the Salmonella test. MuLat. Res.
97 :26 7-281, 1982 .
Bishop, J.M., and H. Varmus. Functions and origins of
retroviral transforming genes, pp. 999-1108. In R. Weiss,
N. Teich, H. Varmus, and J. Coffin, Eds. kNA Tumor
Viruses. New York: Cold Spring Harbor Laboratory, 1982.
26. Boveri, T. Zur Frage der Entstehung maligner Tumoren.
Jena: Gustav Fischer, 1914. 64 pp.
27. Bradley, M.O., B. 8huyon, M.O. Francis, R. Langenbach, A.
Peterson, and E. Huberman. Mutagenesis by chemical agents
in V79 Chinese hamster cells: A review and analysis of
the literature. A report of the GENE-TOX Program. Mutat.
Res. 87:81-142, 1981.
30
OCR for page 31
2 ~ . Bramb i l l a , G., M . Cavanna , A. Pino , and L. Robb iano .
Quantitative correlation among DNA damaging potency of
six N~nitroso compounds and their potency in inducing
tumor growth and bacterial mutation. Carcinogenesis
2 :425-429, 1981.
29. Breelow, N.E., and J.B. Beckwith. Epidemiological
features of Wilms' tumor: Results of the National Wilms'
Tumor Study. J. Natl. Cancer Inst. 68:429-436, 1982.
30. Brown, M.M., J.S. Wassom, H.V. Malling, M.D. Shelby, and
E.S. van Halle. Literature survey of bacterial, fungal,
and Drosophila assay systems used in the evaluation of
selected chemical compounds for mutagenic activity. J.
Nat 1. Cancer Ins t . 62: 841-8 71, 197 9.
31. Brusick, D.J. Principles of Genetic Toxicology. New York:
Plenum Press, 1980. 279 pp.
32. Burnet, F.M. Cancer: Somatic-genetic considerations. Adv.
Can. Res. 28:1-29, 1978.
33. Cairns, J. Mutation selection and the natural history of
cance r . Nature 255: 19 7-200, 19 7 5 .
34. Cairns, J. The origin of human cancers. Nature
289 : 353-35 7, 19 81.
35. Campbell, T.C. Chemical carcinogens and human risk
assessment. Fed. Proc . 39: 2467-2484, 1980.
36. Chang, E.H., M.E. Furth, E.M. Scolnick, and D.R. Lowy.
Tumorigenic transformation of mammalian cells induced by
normal human gene homologous to the oncogen of Harvey
murine sarcoma virus. Nature 297:479-483, 1982.
37. Clayson, D.B. Carcinogens and carcinogenesis enhancers.
Mutat. Res. 86:217-229, 1981.
38. Clive, D. Comparative chemical mutagenicity: Can we make
risk estimates?, pp. 1039-1066. In F.J. de Serres and
M.D. Shelby, Eds. Comparative Chemical Mutagenesis. New
York: Plenum Press, 1981.
39. Clive, D., R.O. Johnson, J.F.S. Spector, A.G. Batson, and
M.M.M. Brown. Validation and characterization of the
L517BY/TK+/ mouse lymph oma mutagen assay system.
Mutat. Res. 59:61-108, 1979.
40. Cohen, A.J., F.P. Li, S. Berg, D.J. Marchetto, S. Tesi,
S.C. Jacobs, and R.S. Brown. Hereditary renal-cel1 carci-
noma associated with a chromosomal translocation..N. Eng.
J. Med. 301:592-595, 1979.
41. Coombs, M.M., C. Dixon, and A-M. Kissonerghis. Evaluation
of the mutagenicity of compounde of known carcinogenic-
ity, belonging to benz ~ aJanthracene, chrysene, and cyclo-
penta ~ a ~ phenanthrene neries, us ing Ame s ' ~ tes t . Cancer
Res. 36 :4525-4529, 1976.
42. Crouch, E., and R. Wilson. Interepecies comparison of
c arc inogenic potency. J. Toxicol. Environ. Health
5: 1095-~lI8, 1979.
te Serres, F.J., and J. Ashby, Eds. Evaluation of
Short-Term Tests for Carcinogens. Report of the Inter-
national Collaborative Program. New York: ElsevieriNorth
Ho l land, 19 81 . 82 7 pp .
31
OCR for page 32
44. Eeken, J.C.J., and F.H. Sobele. Modification of insertion
mutation events in Drosophila by END, MMS, or deficient
DNA~repai r, p. 146. In Environmental Mutagen Society .
Program and Abstracts, San Antonio, TX. Bethesda, MD:
Environmental Mutagen Society, 1983.
45. Fahmy, M.J., and O.G. Fahmy. Altered control of gene
activity in the some by carcinogens. Hutat. Res.
72: 165-172, 1980.
Fahmy, M.J., and O.G. Fahmy. Intervening DNA insertions
and the alterations of gene expression by carcinogens.
Cancer Res. 40 :3374-3382, 1980.
Fishbein, L. Potential carcinogenic and mutagenic indus-
trial chemicals. I. Alkylating agents. J. Toxicol.
Environ. Heal th 6 :1 133-1 17 7 , 1980.
48. Garner, R.C., and P.J. Hertzog. Letter to the editor.
Nature 289:627, 1981.
Glatt, H.R., H. Schwind, F. Za jdela, A. Croisy, P.C.
Jacquignon, and F. Oesch. Mutagenicity of 43 structurally
re lated he terocyc 1 ic compounds and i ts re let ionship to
their carcinogenicity. Mutat. Res. 66 :307-32B, 1979.
50. Gold, L. S., C. Sawyer, N.K. Hooper, W.R. Havender, L.
Bernstein, R. Peto, M.C. Pike, and B.N. Ames. A carcino-
genic potency data base of the standardized resul~cs of
animal bioassays. Cancer Res. (~ubmitted for publication)
51. Harris, H. Some thoughts about genetics, differentiation,
and malignancy. Somat. Cell Genet. 5:923-930, 1979.
Harvey, R.G. Polycyclic hydrocarbons and cancer. Amer.
Sci. 70: 386-393, 1982.
53. Hoel, D.G., N.L. Raplan, and M.W. Anderson. Implication
o f nonlinear kinetics on ri~k estimation in carcino-
genesis. Science 219 :1032-1037, 1983.
54. Ilollstein, M., J. McCann, F.A. Angelosanto, and W.W.
Nichols. Short-term tests for carcinogens and mutagens.
Mutat. Res. 65: 133-226, 1979.
55. Hooper, K., L. S. Gold, and B.N. Ames. The carcinogenic
potency of ethylene dichloride in two animal bioassays:
comparison of inhalation and gavage studies, pp. 65-81.
In 8anbury Report 5. Ethylene Dichioride: A Potential
Health Risk? New York: Co ld Spr ing Harbor Laboratory,
1980.
56. Horn, L. J. Kaldor, and J. McCann. ~ comparison of
alternative measures of mutagenic potency in the
Salmonella (Ames) test. Mutat. Res. 109 :131-141, 1983.
Huberman, E. Mutagenesis and cell transformation of
mammal fan cells in culture by chemical carcinogens. J.
Environ. Path. Toxicol . 2: 29-42, 1978.
58. International Agency for Research on Cancer. IARO
Monographs on the Evaluation of Carcinogenic Risk of
Chemicals to Man. Supplement 4. Lyon, France: Inter~
na~ciona1 Agency for Research on Cancer, 1982.
32
OCR for page 33
59 ~
International Commission for Protection against Environ-
mental Mutagens and Carcinogens, Committee 2. Final
report: Mutagenesis testing as an approach to carcino-
genesis testing. Mutat. Res. 99: 73-91, 1982.
60. Jones , C.A., P.J. Marlino, W. Lijinsky, and E. Huberman.
The relationship between the carcinogenicity and muta-
genicity of nitrosamines in a hepatocy~ce mediated muta-
genicity assay. Carcinogenesis 2:1075-1077, 1981.
61. Klein, G. Lymphoma development in mice and humans:
Diversity of initiation is followed by convergent carton
genetic evolution. Proc . Nat 1. Acad . Sci . U. S .A.
76: 2442-2446, 1979.
62. Klein, G. The role of gene dosage and genetic trans-
positions in carcinogenesis. Nature 294: 313-318, 1981.
63. Knudson, A.G. Genetics and the etiology of human cancer.
Adv. Hum. Genet . 1: I-51, 1977.
64. Knudson, A.G., A.T. Meadows, and W.W. Nichols. Chromo-
somal deletion and retinoblastoma. N. Eng. J. Med.
295:1120-1123, 1976.
65. Kopelovich, L. Genetic predisposition to cancer in man:
In vitro studies. Internatl. Rev. Cytol. 77 :63-88, 1982.
66. Kraemer, K.H. Xeroderma pigmentosum, pp. I-33. In D. J.
Demis and J. McGuire, Ede. Clinical Dermatology. Vol. 4.
Unit 19-7. New York: Harper and Row, 1980.
67. Magee, P.N. The relationship between mutagenesis, carci-
nogenesis and teratogenesis, pp. 15-27. In D. Scott, B.A.
Bridges, and F.H. Sobels, Eds. Progress in Genetic Toxi-
cology. New York: Elsevier/North Holland, 1977.
68. Margolin, B.H., N. Kaplan, and E. Zeiger. Statistical
analysis of the Ames Salmonella/microsome test. Proc.
Natl. Acad. Sci. U.S.A. 78:3779-3783, 1981.
69. Marx, J.L. Do tumor promoters affect DNA after all?
Science 219:158-159, 1983.
70. McCann, J. Short-term tests and cancer policy, pp. 149-
161. In J.C. McDonald, Ed. Recent Advances in Occupa-
tional Health. New York: Churchill Livingston, 1982.
71. McCann, J., and B.N. Ames. Detection of carcinogens as
mutagens in the Salmonella/microsome test: Assay of 300
chemicals: Discussion. Proc. NatI. Acad. Sci. U.S.A.
73:950-954, 1976. -
72. McCann, J., and B.N. Ames. The Salmonella/microsome
mutagenicity test: Predictive value for animal carcino-
genicity, pp. 1431-1450. In H.H. Hiatt, 3.D. Watson, and
J.A. Winsten, Ede. Origins of Herman Cancer. Human Risk
Assessment. Book C. New York: Cold Spring Harbor Labora-
tory, 1977.
73. McCann, J., E. Choi, E. Yamasaki, and B.N. Ames.
Detection o f carcinogens as mutagens in the Salmonel la/-
microsome test: Assay of 300 chemicals. Proc. NatI. Acad
Sci . U. S .A. 72: 5135-5139, 1975.
33
OCR for page 34
74. McCann, J., L. Born, G. Litton, J. Kaldor, R. ~lagaw, L.
Bernstein, and M. Pike. Short-term tense for carcinogens
and mutagens: A data base designed for comparative quan-
titative analysis. In L. Goldberg, Ed. Structure Activity
as a Predictive Tool in Toxicology. Fundamentals,
Methods, and Applications. Washington, D.C: Hemisphere
Pres ~ . (in pres s)
75. McCann, J., J. Raldor, L. Horn, and R. Siegel. Applica-
tions of short-term tests to problems in cancer risk
assessment: Potency, the Salmonella test, and inter
species comparisons. In EPRI Workshop on Extrapolation
from Animal Studies to Man. Proceedings of a Conference.
Carme l, California. (in pres ~)
76. McKusick, V.A. Mendelian inheritance in man: Catalogs of
autosomal dominant, autosomal recessive, and X-linked
phenotypes. 5th ed. Baltimore: Johns Hopkins Univ. Press,
1978. 975 pp.
7 7. Meselson, M., and K. Russell. Comparisons of carcinogenic
and mutagenic potency, pp. 1473-1481. In H.H. Hiatt, J.D.
Watson, and J.A. Winsten, Eds. Origins of Human Cancer.
Human Ri ok Asses sment . Book C . New York: Cold Spring
Harbor Laboratory, 1977.
78. Mohn, G. R. Bacterial systems for carcinogenicity testing.
Mutat. Res. 87 :191-210, 1981.
79. Mohn, G.R., and J. Ellenberger. Appreciation of the value
of different bacterial test systems for detecting and
ranking chemical mutagens. Arch. Toxicol. 46:45-60, 1980.
80. Moolgavkar, S.H., and A.G. Knudson. Mutation and cancer:
A model for human carcinogenesis. J. Natl. Cancer Inst.
66: 103 7-1052, 1981.
81. More speculation about oncogenes. Nature 300:213' 1982.
82 . Nagao , M., T. Sugimura , and T. Matsushima. Environmental
mutagens and carcinogens. Ann. Rev. Genet. 12 :117-159,
1978.
83. Nat tonal Research Council, Committee for a Study on
Saccharin and Food Safety Policy. Saccharin: Technical
Assessment of Risks and Benefits. Part I. Saccharin and
Its Impuritie ~ . Washington, D.C.: National Academy of
Sciences, 1978. 248 pp.
84. National Research Council, Committee on Chemical
Environmental Mutagens. Identifying and Estimating the
Genetic Impact of Chemical Mutagens. Washington, D.C.:
National Academy Press, 1933. 295 pp.
85. National Research Council, Environmental Studies Board.
Achievements and problems in contemporary pest control,
pp. 27-101. In Pest Control. An Assessment of Present and
Al ternat ive Te chnologies . Vo ~ . I . Contemporary Pes t Con-
trol Practices and Prospects. The Report of the Executive
Committee. Washington, D.C.: National Academy of
Sc fence a, 19 7 5 .
34
OCR for page 35
86. Nevers, P., and H. Saedler. Transposable genetic elements
as agents of gene instability and chromosomal rearrange-
mente. Nature 268: 109-115 ~ 1977.
Parodi, S., and G. Brambilla. Relationships between
mutation and transformation frequencies in mammalian
cells "in vitro" witch chemical carcinogens. Mutat. Res.
47:53-74, 1977.
B8. Parodi, S., S. De Flora, M. Cavanna, A. Pino, L.
Robbiano, C. Bennicelli, and G. Brambilla. DNA-damaging
activity in vivo and bacterial mutagenicity of sixteen
hydras ine derivat ive s a ~ re lated quant itat ive ly t o the ir
carcinogenicity. Cancer Res. 41 :1469-1482, 1981.
89. Parodi , S ., M. Taningher, P. Boero , and L. Santi . Quanti-
tat ive correlations amongst alkaline DNA fragmentation,
DNA covalent binding, mutagenicity in the Ames test and
carcinogenicity, for 21 compounds. Mutat. Res. 93 :1-24,
1982.
90. Parry, J.M., Ed. The U.K.E.M.S. Genotoxicity Trial 1981.
Mutat. Res. 100~-4~: I-447, 1982.
91. Payne, G. S., S.A. Courtneidge, L. B. Crittenden, A.M.
Fadly, J.M. Bishop, and H.E. Varmus. Analysis of avian
leukos is v irus DNA and RNA in bureal tumors: Viral gene
expression is not required for maintenance of the tumor
state. Cell 23:311-322, 1981.
92. Peto, J. Genetic predisposition to cancer, pp. 203-213.
In J. Cairns, J.L. Lyon, and M. Skolnick, Eds. Cancer
Inc idence in De f ined Populat ions . Banbury Report 4 a New
York: Co ld Spring Harbor Laboratory, 1980.
Poirier, L.A., and F.~. de Serres. Initial National
Cancer Institute studies on mutagenesis as a prescreen
for chemical carcinogens: An appraisal. J. NatI. Cancer
Inst. 62: 919-926, 1979.
94. Poirier, L.A., and E.K. Weisburger. Selection of carcin~
yens and related compounds tested for mutagenic activity.
J. Natl. Cancer Ins~c. 62 :833-840, 1979.
95. Prakash, K., O.W. McBride, D.C. Swan, S.G. Devare, S.R.
Tronick, and S.A. Aaronson. Molecular c loning and chromo-
somal mapping of a human locus related to the transform-
ing gene of Moloney murine sarcoma virus. Proc. Natl.
Acad. Sci. U.S.A. 79:5210-5214, 1982.
Probst, G.S., R.E. McMahon, L.E. Hill, C.Z. Thompson,
J. K . Epp, and S. B . Nea 1. Chemical I=induced 1lnscheduled
DNA synthesis in primary rat hepatocyte cultures: ~ co~
parison with bacterial mutagenicity using 218 compounds.
Environ. Mutagen. 3 :11-32, 1981.
97. Purchase, I.F.H. An appraisal of predictive test~ for
c arc inogenicity. Mutat. Res. 99: 53-71, 1932.
98. Purchase. I.F.H. Inter-epecies comparisone of carcino~
genicity. Brit. J. Cancer 41:454-463, 1980.
35
OCR for page 36
99. Purchase, I.F.H., E. Longstaff, and J. Ashby. Evaluation
of six short-term tests for detecting organic chemical
carcinogens and recommendations for their use. Nature
264:624-627, 1976.
100. Purchase, I.F.ll., E. Longstaff, J. Ashby, J.A. Styles , D.
Anderson, P.A. Lefevre, and F.R. Westwood. An evaluation
of 6 short-term tests for detecting organic chemical car-
cinogens. Brit. J. Cancer 37 :873-959, 1978.
10 1 . Re ddy , E. P ., R. K. Reynolds , E . Santos , and M. Barbac id . A
point mutation is responsible for the acquisition of
transforming properties by the T24 human bladder carci-
noma oncogene. Nature 300 :149-152, 1982.
102. Rinkus, S.J., and M.S. Legator. Chemical characterization
of 465 known or suspected carcinogens and their correla-
tion with mutagenic activity in the Salmonella typhi-
murium system. Cancer Res. 39: 3289-3318, 1979.
103. Rinkus, S.J., and M. S. Legator. Salmonella revisited: A
reply to Ames and McCann. Cancer Res. 41: 4196-4203, 1981.
104. Rosenkranz, H.S., and L.A. Poirier. Evaluation of the
mutagenicity and DNA~odifying activity of carcinogens
and noncarcinogens in microbial systems. J. Natl. Cancer
Inst . 62 :873-892, 1979.
105. Rubin, H. Is somatic mutation the major mechanism of
ma 1 ignan t bans f ormat ion? J . Nat 1 . Cancer Ins t .
64: 995-1000, IgBo.
106. Sabin, A.B. Suppression of malignancy in human cancer
cells: Issues and chat lenge s . Proc . Nat l . Acad . Sci .
U. S.A. 78: 7129-7133, 1981.
107. Sawyer, C., R. Peto, L. Bernstein, and M.C. Pike. Calcu-
lation of carcinogenic potency from lon~term animal
carcinogenesis experiments. Biometrics. (in pres s)
108. Scribner, N.K., B. Woodworth, G.P. Ford, and J.D.
Scribner. The influence of molecular size and partition
coefficients on the predictability of tumor initiation in
mouse skin from mutagenicity in Salmonella typhimurium.
Care inogenesis 1 715-719, 1980.
109. Smith, R.J. NCI bioassays yield a trail of blunders.
Science 204 :1287-1292, 19 79.
110. Spira, J., F. Wiener, S. Ohno, and G. Klein. Is erisomy
cause or consequence of murine T cell leukemia develops
meet? Studies on Roberteonian tranelocation in mice.
Proc. Natl. Acad. Sci. U. S.A. 76: 6619-6621, 1979.
Ill. Squire, R.A. Human risk assessment from animal data, pp.
493-501. In S.K. Bandal, G.J. Marco, L. Golberg, and M.L.
Leng, Eds. The Pesticide Chemist and Modern Toxicology.
Washington, D.C.: American Chemical Society, 1981.
112. Squire, R.A. Ranking animal carcinogens: A proposed
regulatory approach. Science 214: 877-880, 1981.
113. Stead, A.G., V. Hasselblad, J.P. Creason, and L. Claxton.
Modeling the Ames test. Mutat. Res. 85: 13-27, 1981.
36
OCR for page 37
.
114. Straus, 1). S. Somatic mutation, cellular differentiation,
and cancer causation. J . Nat 1. Cancer Inst . 67: 233-241,
1981.
115. Swan, D.C., O.W. McBride, K.C. Robbins, D.A. Keithiey,
E.P. Reddy, and S .A. Aaronson. Chromosoma1 mapping of the
simian sarcoma virus one gene analogue in human cells.
Proc . Natl . Acad. Sci. U. S .A. 79 :4691-4695, 1982.
116. Tabin, C.J., S.M. Bradley, C.I. Bargmann, R.A. Weinberg,
A.G. Papageorge, E.M. Scolnick, R. Dhar, D.R. Lowy, and
E.H. Chang. Mechanism of activation of a human oncogene.
Nature 300: 143-149, 1982.
117. Venitt, S. Bacterial mutation as an indicator of carcin'
genicity. Brit. Med. Bull. 36:57-62, 1980.
118. Venitt, S. (Coordinator). UKEMS collaborative genotax-
icity trial: Bacterial mutation tests of 4-chloromethyl-
biphenyl, 4-hydroxymethy~biphenyl and benzyl chloride:
Analysis of data from 17 laboratories. Mutat. Res.
100:91-109, 1982.
119. Wiener, F., H. Babonits, J. Spira, U. Bregula, G. Klein,
R.~. Merwin, R. Asof~ky, R. Lynes, and G. Haughton.
Chromosome 15 trisomy in spontaneous and care inogen-
induced murine lymphomas of B-cell origin. Int. J. Cancer
2 7: 51-5B, 1981.
Zi=~ermann, F.K. Can we determine mutagenicity or only a
mutagenic potential? Mutat . Res. 92: 3-7, 1982.
37
OCR for page 38
Representative terms from entire chapter:
carcinogenic potency
